(Q50682333)

17 March 2018

title

The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis. (English)

1 reference

17 March 2018

0 references

1 reference

9

1 reference

17 March 2018

author name string

Hosen N

1

1 reference

17 March 2018

Shirakata T

2

1 reference

17 March 2018

Nishida S

3

1 reference

17 March 2018

Yanagihara M

4

1 reference

17 March 2018

Tsuboi A

5

1 reference

17 March 2018

Kawakami M

6

1 reference

17 March 2018

Oji Y

7

1 reference

17 March 2018

Oka Y

8

1 reference

17 March 2018

Tan B

10

1 reference

17 March 2018

Sugiyama H

11

1 reference

17 March 2018

Weissman IL

12

1 reference

17 March 2018

publication date

24 May 2007

1 reference

17 March 2018

published in

Leukemia

1 reference

17 March 2018

volume

21

1 reference

17 March 2018

issue

8

1 reference

17 March 2018

page(s)

1783-1791

1 reference

17 March 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404752

exact match

0 references

cites work

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Cancer immunotherapy targeting Wilms' tumor gene WT1 product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Alternative splicing and genomic structure of the Wilms tumor gene WT1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

WT-1 is required for early kidney development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

The purification and characterization of fetal liver hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Purification and characterization of mouse hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

The Wilms' tumor gene Wt1 is required for normal development of the retina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Role of the WT1 tumor suppressor in murine hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Isolation of a candidate human hematopoietic stem-cell population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404752

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404752

1 reference

17 March 2018

Dimensions Publication ID

1045314482

0 references

1 reference

17 March 2018